Showing results (2151-2160 of 2,589) with videos related to

Sort By:
Pageof 259
Molecular Oncology|September 16, 2021
Circulating tumour DNA is a promising biomarker for risk stratification of central chondrosarcoma with IDH1/2 and GNAS mutationsIben Lyskjaer, Christopher Davies, Anna-Christina Strobl, et al.
Molecular Oncology|August 15, 2021
EWS-FLI1-targeting peptide identifies Ewing sarcoma tumor boundaries and lymph node metastasis via near-infrared imagingYu Wang, Hengtang Mai, Ying Yuan, et al.
Molecular Oncology|August 15, 2021
Prolonged estrogen deprivation triggers a broad immunosuppressive phenotype in breast cancer cellsDaniela Hühn, Pablo Martí-Rodrigo, Silvana Mouron, et al.
Molecular Oncology|May 12, 2020
Long non-coding NR2F1-AS1 is associated with tumor recurrence in estrogen receptor-positive breast cancersAnna Sanchez Calle, Tomofumi Yamamoto, Yumi Kawamura, et al.
Molecular Oncology|May 12, 2020
Classification of diffuse lower-grade glioma based on immunological profilingFan Wu, Zhi-Liang Wang, Kuan-Yu Wang, et al.
Molecular Oncology|May 4, 2021
Unveiling mutational dynamics in non-small cell lung cancer patients by quantitative EGFR profiling in vesicular RNALuigi Pasini, Michela Notarangelo, Alessandro Vagheggini, et al.
Molecular Oncology|May 4, 2021
Bispecific antibodies come to the aid of cancer immunotherapyIvano Amelio, Gerry Melino, Arnold J Levine
Molecular Oncology|May 1, 2021
SENP3 loss promotes M2 macrophage polarization and breast cancer progressionMing Xiao, Qi Bian, Yimin Lao, et al.
Molecular Oncology|June 11, 2020
Identification and validation of a combined hypoxia and immune index for triple-negative breast cancerShaoquan Zheng, Yutian Zou, Jie-Ying Liang, et al.
Molecular Oncology|June 14, 2020
An unbiased high-throughput drug screen reveals a potential therapeutic vulnerability in the most lethal molecular subtype of pancreatic cancerChun-Hao Pan, Yuka Otsuka, BanuPriya Sridharan, et al.
Pageof 259